Eisai and Clinilabs Drug Development Corporation conducted an analysis of Lemborexant (LEM) to determine its effectiveness as a treatment for insomnia. LEM is a competitive dual orexin-receptor antagonist that has been approved in multiple countries for the treatment of insomnia in adults. The analysis found that LEM helps improve sleep duration, daytime functioning, and fatigue [...]

Gary Zammit, President and CEO of Clinilabs Drug Development Corporation, was at the ASCP conference in Miami Beach in May, where Dr. Zammit and the team at Eisai Inc. discussed the "Effect of Lemborexant on Sleep Architecture in Adults and Elderly Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease," presented on Poster #59.

Contribute to Brain Health Research and take the Smell Test Challenge Today! Many may be surprised to learn that our sense of smell is linked to brain health. Although one in two people over age 60 may be living with smell loss, many do not know it until they are tested. Monitoring your [...]

Find narcolepsy and idiopathic hypersomnia clinical trials easily at narcolepsyproject.com     CLINILABS DRUG DEVELOPMENT CORPORATION ANNOUNCES THE LAUNCH OF NARCOLEPSYPROJECT.COM, A WEBSITE DESIGNED TO HELP PEOPLE WITH NARCOLEPSY AND IDIOPATHIC HYPERSOMNIA FIND CLINICAL TRIALS MORE EASILY Eatontown, NJ, May 1, 2024 – Clinilabs Drug Development Corporation today announced the launch of NarcolepsyProject.com, [...]

#Clinilabs is proud to have collaborated with eight researchers from leading academic medical centers in the US and Europe, Idorsia Pharmaceuticals Ltd, and  Beacon Biosignals on the recent publication featured in SLEEP entitled: “Effect of daridorexant on sleep architecture in patients with chronic insomnia disorder - A pooled post hoc analysis of two randomized Phase 3 [...]

Clinilabs Events Join us for two exciting events at the ASENT meeting! Gary K. Zammit, PhD will be participating in the ASENT Training in Clinical Trials course Panel of Successful Trialists before the ASENT meeting. Overview: This panel discussion will introduce researchers and clinicians to the principles of neurotherapeutic clinical trial development and implementation and [...]

Join us at World Sleep Society's Annual event from October 20th - October 25th in Rio de Janeiro, Brazil.  This event will feature an exciting program of scientific presentations, courses, and social events dedicated to advancing sleep health worldwide. Come meet with us and find out how we can be your clinical trial partner. Dr. [...]

Pharmaceutical companies have used experimental models of transient insomnia to assess the sleep-promoting effects of investigational drugs for over 40 years.  These models have included the "first-night effect" model, a parallel-group design that assessed drug effects when sleep was recorded in normal, healthy subjects who slept in a new or novel environment for the [...]

Clinilabs congratulates Larimar Therapeutics Inc. on their Topline Phase 1 Clinical Trial Data in patients with Friedreich’s Ataxia! We are proud to have been part of this clinical trial and to have worked with this partner who is dedicated to bringing life changing treatments to patients with this rare disease. To learn more about [...]